Immunome
IMNM
#4821
Rank
โ‚น188.01 B
Marketcap
โ‚น1,592
Share price
-0.81%
Change (1 day)
-0.91%
Change (1 year)

Earnings for Immunome (IMNM)

Earnings in 2026 (TTM): -โ‚น24.85 Billion

According to Immunome's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น20.95 Billion a decrease over its 2024 earnings that were of -โ‚น14.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunome from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น24.85 Billion18.64%
2025 -โ‚น20.95 Billion46.04%
2024 -โ‚น14.35 Billion434.17%
2023 -โ‚น2.69 Billion-22.15%
2022 -โ‚น3.45 Billion46.39%
2021 -โ‚น2.36 Billion41.63%
2020 -โ‚น1.67 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.6 Billion-42.27%๐Ÿ‡บ๐Ÿ‡ธ USA